Forte Biosciences, Inc.
FBRXDelisted- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001419041
Forte Biosciences, Inc. was delisted in 2026; its insiders filed their last Form 4 on Aug 27, 2026; 86 institutions reported holding it in 13F filings for Q2 2026, worth $432.7M in total; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Forte Biosciences, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Forte Biosciences, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Kornfeld Steven | Director | 0 | Aug 27, 2026 | 2 |
| Brun Scott C. | Director | – | Aug 27, 2026 | 2 |
| Gryska David W | Director | 0 | Aug 27, 2026 | 2 |
| Vincent Richard G | Director | – | Aug 27, 2026 | 2 |
| Finck Barbara K | Director | – | Aug 27, 2026 | 1 |
| Kapoor Shivpreet Singh | Director | – | Aug 27, 2026 | 2 |
| Doberstein Stephen K | Director | – | Aug 27, 2026 | 2 |
| Riley Antony A | CHIEF FINANCIAL OFFICER | 0 | Aug 27, 2026 | 7 |
| Wagner Paul A. | SEE REMARKS | 0 | Aug 27, 2026 | 7 |
| Williams Donald Allen | Director | 59,405 | Aug 22, 2024 | 0 |
| Eichenfield Lawrence | Director | – | Aug 22, 2024 | 0 |
| Chen Hubert C | See remarks | 93,405 | Jan 3, 2024 | 0 |
| Walker Patricia S | Director | – | Jun 2, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 2, 2026 (view filing) | Dec 30, 2025 | 3 days | Riley Antony ACHIEF FINANCIAL OFFICER | PPurchase | +9.68K | $26.33 | +$254.9K | +30.4%41.5K after | |
| Nov 22, 2024 (view filing) | Nov 21 | 1 day | Riley Antony ACHIEF FINANCIAL OFFICER | PPurchase | +22.5K | $5.55 | +$125.0K | +272.5%30.8K after | |
| Dec 20, 2023 (view filing) | Dec 18 | 2 days | Wagner Paul A.See Remarks | PPurchase | +10.0K | $0.75 | +$7.50K | +0.6%1.82M after | |
| Dec 15, 2023 (view filing) | Dec 13-14 | 2 days | Wagner Paul A.See Remarks | PPurchase | +20.5K | $0.7097 | +$14.6K | +1.1%1.81M after | 2 lots |
| Dec 12, 2023 (view filing) | Dec 11-12 | 1 day | Wagner Paul A.See Remarks | PPurchase | +29.8K | $0.65 | +$19.4K | +1.7%1.79M after | 2 lots |
| Dec 8, 2023 (view filing) | Dec 7-8 | 1 day | Wagner Paul A.See Remarks | PPurchase | +51.2K | $0.5917 | +$30.3K | +3.0%1.76M after | 2 lots |
| Nov 22, 2023 (view filing)5:51 PM ET | Nov 20-22 | 2 days | Wagner Paul A.See Remarks | PPurchase | +7.37K | $0.4371 | +$3.22K | +0.4%1.71M after | 4 lots |
| Dec 19, 2022 (view filing) | Dec 15-16 | 4 days | Wagner Paul A.See Remarks | PPurchase | +100.0K | $1.05 | +$104.8K | +7.8%1.38M after | 2 lots |
| Sep 8, 2021 (view filing) | Sep 7 | 1 day | Wagner Paul A.See Remarks | SSale | −1.00M | $4.35 | −$4.35M | −43.9%1.28M after | |
| Sep 7, 2021 (view filing) | Sep 7 | Same day | Riley Antony AChief Financial Officer | SSale | −25.0K | $4.24 | −$106.1K | −69.3%11.1K after | 2 lots |